Gene regulation under low oxygen: holding your breath for transcription

Trends in Biochemical Sciences

Volumn 32, Issue 8, 2007, Pages 389-397

  Rocha, Sonia ^a  

^a State Key Laboratory of Plant Physiology and Biochemistry   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBONATE DEHYDRATASE; CERULOPLASMIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENDOGLIN; ERYTHROPOIETIN; FERROCHELATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE TRANSPORTER 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEPTIN; MICRORNA; NUCLEOPLASMIN; OXYGEN; PHOSPHOPROTEIN PHOSPHATASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BNIP3; PROTEIN SWI; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR SNF; TRANSFERRIN; VASCULOTROPIN RECEPTOR 1;

CELL DEATH; CELL GROWTH; CELL METABOLISM; CELL SURVIVAL; CHROMATIN STRUCTURE; DNA REPLICATION; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMAN; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANOXIA; CHROMATIN; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1; MICRORNAS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MODELS, THEORETICAL; OXYGEN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 34547153223     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2007.06.005     Document Type: Review

References (68)

1. Garcia J.A. HIFing the brakes: therapeutic opportunities for treatment of human malignancies. Sci. STKE 337 (2006) pe25
2. Bardos J.I., and Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta 1755 (2005) 107-120
3. Yang J., et al. Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor. J. Biol. Chem. 280 (2005) 36047-36054
4. Qin C., et al. Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis. Clin. Cancer Res. 7 (2001) 818-823
5. Maynard M.A., et al. Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J. 19 (2005) 1396-1406
6. Maynard M.A., et al. Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278 (2003) 11032-11040
7. Kotch L.E., et al. Defective vascularization of HIF-1α-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 209 (1999) 254-267
8. Compernolle V., et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8 (2002) 702-710
9. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9 (2003) 677-684
10. Hu C.J., et al. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in stem cells. Mol. Cell. Biol. 26 (2006) 3514-3526
11. Dery M.A., et al. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 37 (2005) 535-540
12. Fandrey J., et al. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc. Res. 71 (2006) 642-651
13. Kaelin W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74 (2005) 115-128
14. Lando D., et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
15. Schofield C.J., and Ratcliffe P.J. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 338 (2005) 617-626
16. Ruas J.L., and Poellinger L. Hypoxia-dependent activation of HIF into a transcriptional regulator. Semin. Cell Dev. Biol. 16 (2005) 514-522
17. Ruas J.L., et al. Role of CBP in regulating HIF-1-mediated activation of transcription. J. Cell Sci. 118 (2005) 301-311
18. Cockman M.E., et al. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14767-14772
19. Cummins E.P., et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18154-18159
20. Kasper L.H., et al. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J. 24 (2005) 3846-3858
21. Kasper L.H., and Brindle P.K. Mammalian gene expression program resiliency: the roles of multiple coactivator mechanisms in hypoxia-responsive transcription. Cell Cycle 5 (2006) 142-146
22. Wenger R.H., et al. Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005 (2005) re12
23. Elvidge G.P., et al. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α, HIF-2α, and other pathways. J. Biol. Chem. 281 (2006) 15215-15226
24. Ameri K., et al. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells. Blood 103 (2004) 1876-1882
25. Ameri K., et al. Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene 26 (2007) 284-289
26. Wellmann S., et al. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J. Cell Sci. 117 (2004) 1785-1794
27. Rong Y., et al. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res. 66 (2006) 7067-7074
28. Wouters B.G., et al. Control of the hypoxic response through regulation of mRNA translation. Semin. Cell Dev. Biol. 16 (2005) 487-501
29. Miyoshi A., et al. Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1α-independent manner. Int. J. Oncol. 29 (2006) 1533-1539
30. Makino Y., et al. Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J. Biol. Chem. 282 (2007) 14073-14082
31. Lee S.J., et al. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2. Cell Death Differ. 14 (2007) 1106-1116
32. Anderson C.J., et al. Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 25 (2006) 61-69
33. Bi M., et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24 (2005) 3470-3481
34. Koritzinsky M., et al. The hypoxic proteome is influenced by gene-specific changes in mRNA translation. Radiother. Oncol. 76 (2005) 177-186
35. Liu L., et al. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 21 (2006) 521-531
36. Sonenberg N., and Dever T.E. Eukaryotic translation initiation factors and regulators. Curr. Opin. Struct. Biol. 13 (2003) 56-63
37. Proud C.G. Introduction. Oncogene 25 (2006) 6346
38. Hardie D.G., et al. AMP-activated protein kinase - development of the energy sensor concept. J. Physiol. 574 (2006) 7-15
39. Schwarzer R., et al. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24 (2005) 1138-1149
40. Blais J.D., et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol. Cell. Biol. 26 (2006) 9517-9532
41. Wek R.C., et al. Coping with stress: eIF2 kinases and translational control. Biochem. Soc. Trans. 34 (2006) 7-11
42. Kent O.A., and Mendell J.T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25 (2006) 6188-6196
43. Lu J., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
44. Volinia S., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2257-2261
45. Hua Z., et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 1 (2006) e116
46. Kulshreshtha R., et al. A microRNA signature of hypoxia. Mol. Cell. Biol. 27 (2007) 1859-1867
47. Hebert C., et al. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol. Cancer 6 (2007) 5
48. Cvetic C.A., and Walter J.C. Getting a grip on licensing: mechanism of stable Mcm2-7 loading onto replication origins. Mol. Cell 21 (2006) 143-144
49. Gasser S., and Raulet D. The DNA damage response, immunity and cancer. Semin. Cancer Biol. 16 (2006) 344-347
50. Hammond E.M., et al. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 278 (2003) 12207-12213
51. Gibson S.L., et al. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. Cancer Res. 65 (2005) 10734-10741
52. Hammond E.M., et al. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat. Res. 532 (2003) 205-213
53. Hammond E.M., and Giaccia A.J. The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair (Amst.) 3 (2004) 1117-1122
54. van Betteraey-Nikoleit M., et al. Analyzing changes of chromatin-bound replication proteins occurring in response to and after release from a hypoxic block of replicon initiation in T24 cells. Eur. J. Biochem. 270 (2003) 3880-3890
55. Stiff T., et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25 (2006) 5775-5782
56. Wang X.Q., et al. ATR dependent activation of Chk2. J. Cell. Physiol. 208 (2006) 613-619
57. Hammond E.M., et al. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Res. 64 (2004) 6556-6562
58. Mellor J. Dynamic nucleosomes and gene transcription. Trends Genet. 22 (2006) 320-329
59. Varga-Weisz P.D., and Becker P.B. Regulation of higher-order chromatin structures by nucleosome-remodelling factors. Curr. Opin. Genet. Dev. 16 (2006) 151-156
60. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75 (2006) 243-269
61. Jin J., et al. In and out: histone variant exchange in chromatin. Trends Biochem. Sci. 30 (2005) 680-687
62. Schubeler D., et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18 (2004) 1263-1271
63. Seligson D.B., et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435 (2005) 1262-1266
64. Kato H., et al. Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity. J. Biol. Chem. 279 (2004) 41966-41974
65. Fath D.M., et al. Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-α. J. Biol. Chem. 281 (2006) 13612-13619
66. Wang F., et al. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J. Biol. Chem. 279 (2004) 46733-46741
67. Bacon A.L., et al. Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer. Oncogene 26 (2007) 132-141
68. Chen H., et al. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 66 (2006) 9009-9016